Cohen Milstein is conducting an investigation into a widely reported multi-state outbreak of lung disease associated with the use of e-cigarette, vape, e-hookah, and electronic nicotine delivery systems (ENDS) products, including devices, liquids, refill pods, and/or cartridges.*

If you believe that you are suffering from a respiratory illness associated with any of these e-cigarette products and you are interested in potentially participating in this investigation and potential litigation, please complete the form below or contact the Cohen Milstein attorneys in charge of the investigation Leslie M. Kroeger, Partner, 1-877 515 7955 or or Adam J. Langino, Of Counsel, 1-919 890-0563 or

Personal Information:

Cohen Milstein recognizes the importance of your privacy and personal data. Information collected in this questionnaire is confidential and will not be shared or sold.

* On September 12, 2019, the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), state and local health departments, and other clinical and public health partners issued an investigation notice of a multistate outbreak of lung disease associated with the use of e-cigarette products.

Key Facts about E-Cigarette Use, or Vaping from the CDC:

  • Electronic cigarettes – or e-cigarettes — are also called vapes, e-hookahs, vape pens, and electronic nicotine delivery systems (ENDS).
  • E-cigarette brands include Juul, Vuse, Halo, VaporFi, SmokeTip, South Beach Smoke, Vapor4Life, NJOY, Mig Vapor, Blu eCigs, Om Vapors, Green Smoke, Joyetech, Kangertech, E-Cig, EverSmoke, among others.
  • E-cigarettes work by heating a liquid to produce an aerosol that users inhale into their lungs.
  • The liquid can contain: nicotine, tetrahydrocannabinol (THC) and cannabinoid (CBD) oils, and other substances and additives.

Additional Key Facts from the CDC:

  • As of September 11, 2019, at 5:00 p.m., 380 cases of lung illness reported from 36 states and 1 U.S. territory. Six deaths have been reported from 6 states -- all involving the use e-cigarette product use or vaping.
  • Most patients have reported a history of using e-cigarette products containing THC. Many patients have reported using THC and nicotine. Some have reported the use of e-cigarette products containing only nicotine.
  • Symptoms include: nonproductive cough, pleuritic chest pain, or shortness of breath, as well as tachycardia, fever, chills, fatigue, nausea, vomiting, abdominal pain, and diarrhea. Most identified patients have been hospitalized with hypoxemia, which, in some cases, has progressed to acute or subacute respiratory failure.

Reported U.S. States (Associated with related deaths.) – As of September 11, 2019 at 5pm.

  • California, Illinois, Indiana, Kansas, Minnesota, and Oregon.

Reported U.S. States (Associated with Illness) – As of September 11, 2019 at 5pm.

  • AR, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MD, MI, MN, NC, ND, NE, NJ, NM, NV, NY, OH, OR, SC, SD, TN, TX, UT, VA, WA, WI, and WV

Reported U.S. Territories (Associated with Illness) – As of September 11, 2019 at 5pm.

  • USVI

Cohen Milstein’s Complex Tort Litigation practice is a premier, nationally recognized, plaintiffs litigation practice, representing individuals who have suffered catastrophic injuries and environmental harm due to unsafe products, toxic substances, medical negligence, or other forms of injury and abuse.

The following attorneys are overseeing the e-cigarette investigation:

Leslie M. Kroeger, Co-Chair of Cohen Milstein’s Complex Tort Litigation practice
t: 877 515 7955

Adam J. Langino, Of Counsel, Cohen Milstein’s Complex Tort Litigation practice
t: 919 890-0563